Removal of promoter DNA methylation by epigenome editing reverses HBG silencing [RNA-seq]
DNA methylation · human · 40 samples
- What it is
- DNA methylationChemical marks on DNA that help switch genes on or off.
- Organism
- Homo sapiens (human)
- Samples
- 40 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Removal of promoter CpG methylation by epigenome editing reverses HBG silencingNature communications · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE284289_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for beta-value tables or raw IDAT files among the supplementary files.
Also filed as BioProject PRJNA1198349 and SRA study SRP551463. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 40 samples.
How we read this: 12 replicated groups read from 40 sample titles; they account for 40 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8681800 HUDEP-2 WT Rep1 HUDEP-2 WT
- GSM8681801 HUDEP-2 WT Rep2 HUDEP-2 WT
- GSM8681802 HUDEP-2 WT Rep3 HUDEP-2 WT
- GSM8681803 HUDEP-2 WT Rep4 HUDEP-2 WT
- GSM8681804 HUDEP-2 WT Rep5 HUDEP-2 WT
- GSM8681805 HUDEP-2 MBD2Y178F Rep1 HUDEP-2 MBD2Y178F
- GSM8681806 HUDEP-2 MBD2Y178F Rep2 HUDEP-2 MBD2Y178F
- GSM8681807 HUDEP-2 MBD2Y178F Rep3 HUDEP-2 MBD2Y178F
- GSM8681808 HUDEP-2 MBD2Y178F Rep4 HUDEP-2 MBD2Y178F
- GSM8681809 HUDEP-2 MBD2Y178F Rep5 HUDEP-2 MBD2Y178F
- GSM8681810 HUDEP-2 Mock Rep1 HUDEP-2 Mock
- GSM8681811 HUDEP-2 Mock Rep2 HUDEP-2 Mock
- GSM8681812 HUDEP-2 Mock Rep3 HUDEP-2 Mock
- GSM8681813 HUDEP-2 Guide 1 Rep1 HUDEP-2 Guide 1
- GSM8681814 HUDEP-2 Guide 1 Rep2 HUDEP-2 Guide 1
- GSM8681815 HUDEP-2 Guide 1 Rep3 HUDEP-2 Guide 1
- GSM8681816 HUDEP-2 Guide 2 Rep1 HUDEP-2 Guide 2
- GSM8681817 HUDEP-2 Guide 2 Rep2 HUDEP-2 Guide 2
- GSM8681818 HUDEP-2 Guide 2 Rep3 HUDEP-2 Guide 2
- GSM8681819 HUDEP-2 Guide 3 Rep1 HUDEP-2 Guide 3
- GSM8681820 HUDEP-2 Guide 3 Rep2 HUDEP-2 Guide 3
- GSM8681821 HUDEP-2 Guide 3 Rep3 HUDEP-2 Guide 3
- GSM8681822 HUDEP-2 Guide 4 Rep1 HUDEP-2 Guide 4
- GSM8681823 HUDEP-2 Guide 4 Rep2 HUDEP-2 Guide 4
- GSM8681824 HUDEP-2 Guide 4 Rep3 HUDEP-2 Guide 4
- GSM8681825 HUDEP-2 Guide 5 Rep1 HUDEP-2 Guide 5
- GSM8681826 HUDEP-2 Guide 5 Rep2 HUDEP-2 Guide 5
- GSM8681827 HUDEP-2 Guide 5 Rep3 HUDEP-2 Guide 5
- GSM8681828 HUDEP-2 Guide 6 Rep1 HUDEP-2 Guide 6
- GSM8681829 HUDEP-2 Guide 6 Rep2 HUDEP-2 Guide 6
- GSM8681830 HUDEP-2 Guide 6 Rep3 HUDEP-2 Guide 6
- GSM8681831 HUDEP-2 All Guides Rep1 HUDEP-2 All Guides
- GSM8681832 HUDEP-2 All Guides Rep2 HUDEP-2 All Guides
- GSM8681833 HUDEP-2 All Guides Rep3 HUDEP-2 All Guides
- GSM8681834 HUDEP2_NT_rep1 HUDEP2_NT
- GSM8681835 HUDEP2_NT_rep2 HUDEP2_NT
- GSM8681836 HUDEP2_NT_rep3 HUDEP2_NT
- GSM8681837 HUDEP2_UHRF1gRNA1KO_rep1 HUDEP2_UHRF1gRNA1KO
- GSM8681838 HUDEP2_UHRF1gRNA1KO_rep2 HUDEP2_UHRF1gRNA1KO
- GSM8681839 HUDEP2_UHRF1gRNA1KO_rep3 HUDEP2_UHRF1gRNA1KO
- GSE262797 A one-base therapeutic insertion in the HBG2 distal promoter reactivates γ-globin expression [ChIP-Seq] 10 samples shares hbg, promoter
- GSE243185 Activation of the imprinted Prader-Willi Syndrome locus by CRISPR-based epigenome editing [RNA-seq] 18 samples shares epigenome, editing
- GSE273682 Sustained and specific multiplexed immune checkpoint modulation in CAR T cells induced by targeted epigenome editing 15 samples shares epigenome, editing
- GSE304097 DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression 293 samples shares methylation, silencing
- GSE254366 Epigenome reprogramming through H3K27 and H3K4 trimethylation as a resistance mechanism to DNA methylation inhibition in BRAFV600E-mutated CRC. 36 samples shares methylation, epigenome
- GSE271704 5G-exposed human skin cells do not respond with altered gene expression and methylation profiles [RNA-Seq] 120 samples shares methylation
- GSE281750 The bladder cancer m6A landscape is defined by global methylation dilution and focal 3′-UTR hypermethylation 54 samples shares methylation
- GSE274999 Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs [RNA-Seq] 52 samples shares methylation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.